RIB-X PHARMACEUTICALS, INC.

Profile

Company Names

RIB-X PHARMACEUTICALS, INC.
RIB X PHARMACEUTICALS INC

Addresses

300 GEORGE STREET, SUITE 301, NEW HAVEN, CT 06511

Phone Numbers

203-624-5606

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$29,686,500.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-11-15 
$18,686,500.00 
$67,500,000.00 
$48,813,500.00 
Equity 
2
2011-01-12 
$5,500,000.00 
$22,000,000.00 
$16,500,000.00 
Debt 
1
2010-05-28 
$5,500,000.00 
$15,000,000.00 
$9,500,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
C. BOYD 
 
CLARKE 
DIRECTOR
PALKION INC   |  RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  ALDEYRA THERAPEUTICS, INC.
ROBERT 
 
CONERLY 
EXECUTIVE OFFICER, DIRECTOR
RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  MR. BULLY HOLDINGS, INC.
JONATHAN 
 
FLEMING 
DIRECTOR
RAILRUNNER NA INC   |  MOLECULAR BIOMETRICS INC   |  HYDROCISION INC   |  RIB X PHARMACEUTICALS INC   |  RADIUS HEALTH, INC.   |  AVAXIA BIOLOGICS, INC   |  XENCOR INC   |  GREENLIGHT BIOSCIENCES INC.   |  CONTINUUS PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  AQUACULTURAL RESEARCH CORP   |  Q-STATE HOLDINGS, INC.   |  QURALIS CORP   |  ONC.AI, INC.   |  DICEROS THERAPEUTICS, INC.   |  ENCLEAR THERAPIES, INC.
CECILIA 
 
GONZALO 
DIRECTOR
RIB X PHARMACEUTICALS INC   |  TALON THERAPEUTICS, INC.   |  RIB-X PHARMACEUTICALS, INC.   |  MELINTA THERAPEUTICS, INC. /NEW/
PETER 
 
GREENLEAF 
DIRECTOR
RIB X PHARMACEUTICALS INC   |  CORRIDOR PHARMACEUTICALS, INC.   |  HISTOGENICS CORP   |  EYEGATE PHARMACEUTICALS INC   |  PELTHOS THERAPEUTICS INC.
JONATHAN 
 
LEFF 
DIRECTOR
HANA BIOSCIENCES INC   |  RIB X PHARMACEUTICALS INC   |  TALON THERAPEUTICS, INC.   |  N30 PHARMACEUTICALS, INC.   |  AUDENTES THERAPEUTICS, INC.   |  AVEXIS, INC.   |  APRECIA PHARMACEUTICALS CO   |  PROTEON THERAPEUTICS INC   |  DRACEN PHARMACEUTICALS, INC.   |  ARS PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  CHONDRIAL THERAPEUTICS HOLDINGS, LLC   |  LARIMAR THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AEROVATE THERAPEUTICS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  INNERVACE, INC.   |  BIOMX INC.   |  ELION THERAPEUTICS, INC.   |  AXONIS THERAPEUTICS, INC.
JONATHAN 
S. 
LEFF 
DIRECTOR
RIB-X PHARMACEUTICALS, INC.   |  KEMPHARM, INC
MARK 
 
LEUCHTENBERGER 
EXECUTIVE OFFICER, DIRECTOR
RIB X PHARMACEUTICALS INC   |  MERCATOR THERAPEUTICS, INC.   |  RIB-X PHARMACEUTICALS, INC.   |  ALETA BIOTHERAPEUTICS, INC.   |  NEUROSENSE THERAPEUTICS LTD.
GEORGE 
 
MILNE 
DIRECTOR
RIB X PHARMACEUTICALS INC   |  AMYLYX PHARMACEUTICALS, INC.
GEORGE 
M. 
MILNE, JR. 
DIRECTOR
RESOLVYX PHARMACEUTICALS, INC.   |  RIB-X PHARMACEUTICALS, INC.
HARRY 
H. 
PENNER, JR. 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.
RAYMOND 
 
WHITAKER 
DIRECTOR
FLUIDIGM CORP   |  RIB X PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-11-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-11-15 
2011-01-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-01-12 
2010-06-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#